Product Information
BUMETANIDE 2 MG TABLET is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.1767 per EA under NDC 51672422501. Its NADAC has been published 134 times since Jan 31, 2024.
FDA first approved this application on Jul 24, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672422501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUMETANIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213458FDA Approved
7/24/2023
TE Code
AB
On Market Since
7/24/2023
Pharmacological Classes
Price Statistics
The NADAC for BUMETANIDE 2 MG TABLET has been published 134 times since Jan 31, 2024, and over the history we have for it it has declined 42.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1767 per EA |
|---|---|
| All-time high | $0.3271 (Jul 10, 2024) |
| All-time low | $0.1717 (Jul 22, 2026) |
| 52-week high | $0.2544 |
| 52-week low | $0.1717 |
| Median price | $0.2412 |
| Average price | $0.2390 |
| Largest weekly change | +35.6% (Jun 19, 2024) |
| Weeks tracked | 134 |
| Tracking since | Jan 31, 2024 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUMETANIDE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUMETANIDE 2 MG TABLET, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.1767 per EA (NDC 51672422501), effective Aug 19, 2026.
How has the price of BUMETANIDE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUMETANIDE 2 MG TABLET has declined 42.7%. It has been tracked across 134 weekly CMS publications since Jan 31, 2024.
What are the highest and lowest recorded NADAC prices for BUMETANIDE 2 MG TABLET?
Since Jan 31, 2024, the NADAC for BUMETANIDE 2 MG TABLET has ranged from a low of $0.1717 (Jul 22, 2026) to a high of $0.3271 (Jul 10, 2024), with a median of $0.2412 per EA.
Are there cheaper alternatives to BUMETANIDE 2 MG TABLET?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUMETANIDE 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUMETANIDE 2 MG TABLET?
BUMETANIDE 2 MG TABLET (NDC 51672422501) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.